#Genomics / Postgenomics
- Cell therapy
- Disease modeling
- Stem cells
- Monogenic diseases
As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.Discover >
Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.Discover >
#Genomics / Postgenomics
Postgenomics and biotherapies of monogenic diseases.
I-STEM can be conceptualized with three key terms: “stem cells”, “therapeutics” and “monogenic diseases”. The institute evaluates the therapeutic potential of all types of stem cells in the setting of monogenic diseases. Within this mission, I-STEM explores more particularly substitutive cellular therapies for degenerative diseases on one hand and the use of pathological stem cell lines as targets for the screening of potentially therapeutic compounds on the other.
The teams at I-Stem develop research programs employing embryonic stem cells and induced pluripotent stem cells with the aim of creating therapeutics for rare genetic diseases.
Three major research orientations are forwarded in parallel:
In same field
LBEPS is a laboratory dedicated to the physiology and biology of exercise implementing a translation strategy from the physiology of humans in motion to the study of cellular, molecular, genetic and epigenetic responses to exercise and recoveryDiscover
ART-TG is a pre-GMP stage R&D laboratory aiming to bridge a gap between research and clinical or industrial applications. It has pharmaceutical expertise for product development and product manufacturing, specifically for genomic therapy approaches.Discover
Gene therapy for rare genetic diseases. Research, preclinical and clinical development of gene therapies for neuromuscular and other rare genetic diseases.Discover
Research at LGRK focuses on the homeostasis, regenerative potential and radiosensitivity of human epidermal stem cells.Discover
The Integrare research unit aims to develop effective and safe gene therapies for rare genetic diseases such as neuromuscular disorders, metabolic diseases or blood/immune disordersDiscover
Genomics and postgenomics of biodiversity – Metagenomics of microorganisms from the environment.Discover
The Metabolic Genomics UMR is the fundamental research structure of Genoscope – National Sequencing Center – Study of the chemistry and the diversity of organisms. Genomics of eukaryotes, prokaryotes and metagenomes.Discover
Genomics – Genetic Statistics Research on genetic susceptibility to complex diseases through genomic analyses with a focus on rheumatoid arthritis.Discover
Plant genomics. Detection, analysis and management of plant species polymorphism.Discover
The CNRGH is a national-level center whose mission is to provide high throughput genotyping and sequencing services with the objective of optimizing genetic and genomic research for human diseases.Discover